3 years ago
APLS
AnalystsColleen KusyColleen Kusy's Stock Forecasts
AnalystsColleen Kusy
Sectors:
Industries:
Analyst Ranking
Top 24%
#1232 out of 5271 analysts
Average Return
+9.32%
Win Rate
38%20 out of 52
Risk vs Reward
Poor
Good
Colleen Kusy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Climb Bio IncCLYM | +526.84% | $1.90 | $11.91 | 2025-08-14 - 2026-05-07 | Buy |
Iveric Bio IncISEE | +150.13% | $14.94 | $37.37 | 2022-09-06 - 2023-05-04 | Buy |
Ocular Therapeutix IncOCUL | +149.31% | $3.61 | $9.00 | 2023-09-13 - 2024-09-13 | Buy |
Apellis Pharmaceuticals IncAPLS | +130.26% | $17.81 | $41.01 | 2025-05-07 - 2026-05-07 | Buy |
Apellis Pharmaceuticals IncAPLS | +110.63% | $19.47 | $41.01 | 2025-07-17 - 2026-05-07 | Buy |
Colleen Kusy Analyst Color
Get additional color on Colleen Kusy's coverage of popular stocks
Colleen Kusy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | 3 | Buy | $90.00 | +23.12% | Maintains | 24 days ago |
Climb Bio IncCLYM | 2 | Buy | $12.00 | +0.76% | Maintains | 2 months ago |
Argenx SeARGX | 2 | Hold | $867.00 | +10.12% | Maintains | 2 months ago |
Nuvalent IncNUVL | 3 | Buy | $158.00 | +54.30% | Maintains | 6 months ago |
Cogent Biosciences IncCOGT | 1 | Hold | $34.00 | -2.27% | Maintains | 6 months ago |
Apellis Pharmaceuticals IncAPLS | 13 | Buy | $52.00 | +26.80% | Maintains | 6 months ago |
Ocular Therapeutix IncOCUL | 5 | Buy | $24.00 | +147.93% | Maintains | 7 months ago |
Enliven Therapeutics IncELVN | 3 | Buy | $52.00 | +29.06% | Maintains | a year ago |
Agenus IncAGEN | 4 | Hold | $6.00 | +60.00% | Maintains | a year ago |
Oculis Holding AgOCS | 4 | Buy | $41.00 | N/A | Maintains | a year ago |
Coherus Oncology IncCHRS | 5 | Buy | $6.00 | N/A | Maintains | a year ago |
Mersana Therapeutics IncMRSN | 4 | Hold | $75.00 | N/A | Maintains | 2 years ago |
Oric Pharmaceuticals IncORIC | 1 | Buy | $25.00 | N/A | Reiterates | 2 years ago |
Surface Oncology IncSURF | 5 | Buy | $6.00 | N/A | Maintains | 3 years ago |
Iveric Bio IncISEE | 3 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Harpoon Therapeutics IncHARP | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Aveo Pharmaceuticals IncAVEO | 1 | Hold | $15.00 | N/A | Downgrades | 4 years ago |
Karyopharm Therapeutics IncKPTI | 1 | Buy | $210.00 | N/A | Maintains | 4 years ago |
Iovance Biotherapeutics IncIOVA | 2 | Buy | $34.00 | N/A | Maintains | 4 years ago |
Sab Biotherapeutics IncSABS | 1 | Buy | $230.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.